Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2025-06-25 00:00:00 ET · period of report 2025-06-23 · accession 0001415889-25-018221 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-25 | 2025-06-23 | TBPH | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | -20.0K | 1.73M | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-06-23 | G | D | 20,000 | $0.00 | 1,733,180 | D | — | — | (F1) Bona Fide Gift. No compensation was given to the donor for the gifting of shares. |